Follow the Tatva Chintan Pharma Chem Limited share price and the full insider trade history of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Tatva Chintan Pharma Chem Limited has logged 7 reports. Market capitalisation: €40bn. The latest transaction was filed on 9 February 2026 (Purchase). Among the most active insiders: Ajay Mansukhlal Patel. The full history is free.
7
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
€13m
6 ops.
Sell Volume
10Σ signal
Buys n/a€13m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,606 of 29,062 companies
43.1
score / 100
Value
25
Quality
62
FCF yld-2.1%
Earn yld1.1%
EV/EBITDA42.6x
ROE5.5%
Gross mgn56%
Net mgn8.3%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
233,766 shares@ ₹1,639.6044100.0% of flowEquity SharesSEBI:c376c5d5912e7714336a00da177d2ee4134b9e42
7 of 7 declarations
Acerca de Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited es una empresa especializada en la fabricación de productos químicos para la industria farmacéutica. Cotiza en el mercado XBOM.